These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33156579)

  • 1. INSM1 immunostaining in solid papillary carcinoma of the breast.
    Kudo N; Takano J; Kudoh S; Arima N; Ito T
    Pathol Int; 2021 Jan; 71(1):51-59. PubMed ID: 33156579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
    Seijnhaeve E; Galant C; Van Bockstal MR
    Int J Surg Pathol; 2021 Aug; 29(5):496-502. PubMed ID: 33426999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56.
    Chen JF; Yang C; Sun Y; Cao D
    Pathol Res Pract; 2020 Jun; 216(6):152993. PubMed ID: 32381384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast.
    Yanai H; Ishida M; Yoshikawa K; Tsuta K; Sekimoto M; Sugie T
    Oncol Lett; 2022 Apr; 23(4):137. PubMed ID: 35317025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.
    Mukhopadhyay S; Dermawan JK; Lanigan CP; Farver CF
    Mod Pathol; 2019 Jan; 32(1):100-109. PubMed ID: 30154579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
    Zou Q; Zhang L; Cheng Z; Guo X; Cao D
    Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.
    Roy M; Buehler DG; Zhang R; Schwalbe ML; Baus RM; Salamat MS; Lloyd RV; Rosenbaum JN
    Endocr Pathol; 2019 Mar; 30(1):35-42. PubMed ID: 30523500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future prospective.
    Kawasaki T; Kaira K
    Virchows Arch; 2021 Jul; 479(1):191-194. PubMed ID: 33025295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract.
    Kim IE; Amin A; Wang LJ; Cheng L; Perrino CM
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):687-693. PubMed ID: 31876605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
    Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
    Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors.
    Möller K; Uhlig R; Gorbokon N; Dum D; Menz A; Büscheck F; Luebke AM; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Lebok P; Weidemann S; Lennartz M; Jacobsen F; Clauditz TS; Steurer S; Burandt E; Krech R; Krech T; Marx AH; Sauter G; Simon R; Bernreuther C; Minner S
    Mol Cell Endocrinol; 2024 Feb; 581():112106. PubMed ID: 37951531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.
    Leblebici C; Yeni B; Savli TC; Aydın Ö; Güneş P; Cinel L; Şimşek BÇ; Yıldız P; Tuncel D; Kayahan S
    Ann Diagn Pathol; 2019 Jun; 40():53-58. PubMed ID: 31031215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Utility of INSM1 in Medullary Thyroid Carcinoma.
    Seok JY; Kang M; De Peralta-Venturina M; Fan X
    Int J Surg Pathol; 2021 Sep; 29(6):615-626. PubMed ID: 33650906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features.
    Turkevi-Nagy S; Báthori Á; Böcz J; Krenács L; Cserni G; Kővári B
    Pathol Oncol Res; 2021; 27():1610039. PubMed ID: 34764822
    [No Abstract]   [Full Text] [Related]  

  • 17. A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.
    Kuji S; Watanabe R; Sato Y; Iwata T; Hirashima Y; Takekuma M; Ito I; Abe M; Nagashio R; Omae K; Aoki D; Kameya T
    Gynecol Oncol; 2017 Feb; 144(2):384-390. PubMed ID: 27908529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.
    Tanigawa M; Nakayama M; Taira T; Hattori S; Mihara Y; Kondo R; Kusano H; Nakamura K; Abe Y; Ishida Y; Okabe Y; Hisaka T; Okuda K; Fujino K; Ito T; Kawahara A; Naito Y; Yamaguchi R; Akiba J; Akagi Y; Yano H
    Med Mol Morphol; 2018 Mar; 51(1):32-40. PubMed ID: 28849340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.
    Xin Z; Zhang Y; Jiang Z; Zhao L; Fan L; Wang Y; Xie S; Shangguan X; Zhu Y; Pan J; Liu Q; Huang Y; Dong B; Xue W
    Hum Pathol; 2018 Sep; 79():151-159. PubMed ID: 29885405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulinoma-associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma.
    Minami K; Jimbo N; Tanaka Y; Ogawa H; Hokka D; Nishio W; Yoshimura M; Itoh T; Maniwa Y
    J Surg Oncol; 2020 Aug; 122(2):243-253. PubMed ID: 32346887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.